Same Indication

Ipilimumab vs Irbesartan

Ipilimumab vs Irbesartan: Overview

This comparison examines the pharmacological differences between Ipilimumab and Irbesartan.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Irbesartan β€” 11-15 hours.

Chemical Properties

Molecular Formula: Irbesartan β€” C25H28N6O.

Molecular Weight: Irbesartan β€” 428.5320 g/mol.

Type: Ipilimumab β€” Antibody; Irbesartan β€” Small molecule.